|
Associate Scientist, Clinical Epidemiology, Ottawa Hospital Research Institute
Physician, Hematology (Thrombosis), The Ottawa Hospital
Assistant Professor, Department of Medicine, Faculty of Medicine, University of Ottawa
Research
Dr. Marc Carrier is a clinician scientist specializing in thrombosis. Dr. Carrier's clinical research is focused in venous thromboembolic disease and cancer, including cancer screening, prevention and management. He is currently leading a clinical trial with colleague Dr. Marc Rodger to determine if patients with deep vein blood clots (venous thromboembolism) should be offered extra screening for cancer. He has received funding from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Ontario.
Most Recent Publications (provided by The Ottawa Hospital Library Database)
Robert-Ebadi H;Le GG;Carrier M;Couturaud F;Perrier A;Bounameaux H;Righini M;, (2010 Jan 22), Differences in clinical presentation of pulmonary embolism in women and men, J Thromb Haemost, -> view abstract
Le GG;Carrier M;Tierney S;Majeed H;Rodger M;Wells PS;, (2010 Jan), Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?, J Thromb Haemost, Vol.8, Issue 1, 90-94 -> view abstract
Shen AY;Le GG;Dennie C;Wells PS;Carrier M;, (2010 Feb 24), Incidence and clinical outcomes of occult cancers detected by computed tomographic pulmonary angiography in patients with acute pulmonary embolism, J Thromb Haemost,
Roy L;Laflamme GY;Carrier M;Kim PR;Leduc S;, (2009 Oct 31), A randomised clinical trial comparing minimally invasive surgery to conventional approach for endoprosthesis in elderly patients with hip fractures, Injury, -> view abstract
Le GG;Carrier M;Tierney S;Majeed H;Rodger M;Wells PS;, (2009 Oct 30), Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram- do we really need genotyping?, J Thromb Haemost, -> view abstract
Carrier M;Righini M;Djurabi RK;Huisman MV;Perrier A;Wells PS;Rodger M;Wuillemin WA;Gal GL;, (2009 May), VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies, Thromb Haemost, Vol.101, Issue 5, 886-892 -> view abstract
Wells PS;Le Gal G;Tierney S;Carrier M;, (2009 Jun 10), Practical application of the 10-mg warfarin initiation nomogram, Blood Coagul Fibrinolysis, Vol.20, Issue 6, 403-408 -> view abstract
Carrier M;Le Gal G;Cho R;Tierney S;Rodger M;Lee AY;, (2009 Feb 25), Dose escalation of low molecular weight heparin to manage recurrent venous thromboemblic events despite systemic anticoagulation in cancer patients, J Thromb Haemost, Vol.7, Issue 5, 760-765 -> view abstract
Le Gal G;Kovacs MJ;Carrier M;Do K;Kahn SR;Wells PS;Anderson DA;Chagnon I;Solymoss S;Crowther M;Righini M;Perrier A;White RH;Vickars L;Rodger M;, (2009 Feb 18), Validation of a diagnostic approach to exclude recurrent venous thromboembolism, J Thromb Haemost, Vol.7, Issue 5, 752-759 -> view abstract
Carrier M;Lee AY;, (2009 Feb), Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology, Nat Clin Pract Oncol, Vol.6, Issue 2, 74-84 -> view abstract
Note: This is not a complete list of publications. More publications may be available in The Ottawa Hospital Library database and Pubmed (search by last name and initials).
| |
General Campus
(see 
